Dr. Tiziano Barbui explains how excess blood cell production in certain myeloproliferative neoplasms can impair circulation and why treatments like phlebotomy are used. Excess blood cell production in ...

The Shorespan-007 trial will investigate the new drug among patients with essential thrombocythemia who have not previously received cytoreductive therapy. A second phase 3 clinical trial has been ...

"These patients [with extreme thrombocytosis] had improved overall survival and lower bleeding risk compared to those with normal or low platelet counts at the time of diagnosis." — Marko Lucijanic, ...

Consecutive patients discharged from the orthopaedic unit and admitted to the intensive rehabilitation unit of our hospital were identified. The ward uses multidisciplinary staff and a ...

This report illustrates the relation between pseudohyperkalemia and thrombocytosis associated with myeloproliferative disease. Some laboratory studies on the mechanisms involved, serial observations ...

John Mascarenhas, MD, discusses phase 1 data showing that INCA33989 is a well-tolerated therapy for calreticulin–mutant essential thrombocythemia, with early signs of efficacy and potential disease ...

Change in platelet counts was a common phenomenon after major joint surgery, and elevated PLTC occurred in about half of the patients who were admitted to the rehabilitation centre. Thrombocytosis was ...